New capsule aims for Long-Term control of rare blood disease
NCT ID NCT07177872
Summary
This study is testing the long-term safety and effectiveness of NTQ5082 capsules for adults with paroxysmal nocturnal hemoglobinuria (PNH), a rare and serious blood disorder. It will follow 78 patients who have already benefited from the treatment in earlier studies. The main goal is to see if the capsules continue to help control the disease and are safe to take over a longer period.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PAROXYSMAL NOCTURNAL HEMOGLOBINURIA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences ,
Tianjin, Tianjin Municipality, 300020, China
Contact
Contact
Conditions
Explore the condition pages connected to this study.